Skip to main content
TMS Co., Ltd logo

TMS Co., Ltd — Investor Relations & Filings

Ticker · 4891 ISIN · JP3544960002 T Manufacturing
Filings indexed 40 across all filing types
Latest filing 2024-10-15 Report Publication Anno…
Country JP Japan
Listing T 4891

TMS Co., Ltd. is a clinical-stage company focused on the research, development, manufacture, and sale of drug products, quasi-drugs, and medical devices. Founded by scientists from the Tokyo University of Agriculture and Technology, the company aims to discover and develop transformative medicines for diseases with high unmet medical needs. Its research centers on a group of fungus-derived small molecule compounds known as SMTPs, which exhibit a novel dual mode of action. The company's objective is to create revolutionary drugs for conditions that currently lack effective treatments.

Recent filings

Filing Released Lang Actions
確認書
Report Publication Announcement Classification · 100% confidence The document text contains the header "第2四半期報告書" (Second Quarter Report) and explicitly mentions the period covered: "第21期中間期(自 2024年3月1日 至 2024年8月31日)" (The 21st Interim Period (From March 1, 2024, to August 31, 2024)). This content is a formal confirmation/statement regarding the appropriateness of the interim financial report, filed with the Kanto Local Finance Bureau ("関東財務局長"). This structure strongly indicates a comprehensive financial report for a period shorter than a year. Based on the definitions, this aligns best with the Interim / Quarterly Report (IR) category, as it deals directly with the content of the half-year report, rather than just announcing its publication (RPA) or being a general regulatory filing (RNS). The document length is short, but the content is substantive regarding the interim report's accuracy, making IR more appropriate than RPA.
2024-10-15 Japanese
半期報告書-第21期(2024/03/01-2025/02/28)
Interim / Quarterly Report Classification · 100% confidence The document is a '半期報告書' (Semi-annual Report) filed with the Kanto Local Finance Bureau in Japan. It contains detailed financial statements, management analysis (MDA), and corporate information for the interim period (March 1, 2024, to August 31, 2024). According to the filing definitions, a comprehensive financial report for a period shorter than a full fiscal year that contains actual financial statements is classified as an Interim/Quarterly Report (IR). H1 2025
2024-10-15 Japanese
確認書
Report Publication Announcement Classification · 100% confidence The document text contains Japanese regulatory headers such as "【提出書類】確認書" (Filing Document: Confirmation Document), "【根拠条文】金融商品取引法第24条の4の8第1項" (Legal Basis: Article 24-4-8, Paragraph 1 of the Financial Instruments and Exchange Act), and explicitly mentions "第1四半期報告書" (First Quarter Report) for the period ending May 31, 2024. This structure, which includes confirmation by management regarding the appropriateness of the quarterly report's contents based on financial laws, is characteristic of a formal Japanese quarterly financial filing. In the provided classification scheme, the most appropriate category for a comprehensive quarterly financial report is 'Interim / Quarterly Report' (IR). The document length is short (555 chars), but the content is the substance of the required confirmation for the quarterly report itself, not merely an announcement of its publication.
2024-07-12 Japanese
四半期報告書-第21期第1四半期(2024/03/01-2024/05/31)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) filed by TMS Co., Ltd. in accordance with the Financial Instruments and Exchange Act of Japan. It contains detailed financial statements, including the balance sheet and income statement for the first quarter of the 21st fiscal year (March 1, 2024, to May 31, 2024), as well as management analysis and notes. This meets the criteria for an Interim/Quarterly Report (IR) as it provides substantive financial data and analysis for a period shorter than a full fiscal year. Q1 2025
2024-07-12 Japanese
確認書
Regulatory Filings Classification · 100% confidence The document is titled '確認書' (Confirmation Letter) and explicitly states it is filed under the Financial Instruments and Exchange Act to confirm the accuracy of the contents of the Annual Securities Report (有価証券報告書). According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations, even if they reference a specific report, should be classified as Regulatory Filings (RNS) rather than the report itself. FY 2023
2024-05-29 Japanese
内部統制報告書-第20期(2023/03/01-2024/02/29)
Governance Information Classification · 100% confidence The document is explicitly titled "内部統制報告書" (Internal Control Report) in the cover section and throughout the text. It references the legal basis as Article 24-4-4, Paragraph 1 of the Financial Instruments and Exchange Act (金融商品取引法第24条の4の4第1項), which mandates the filing of an Internal Control Report by listed companies in Japan. The content discusses the framework, scope, criteria, and conclusion regarding the effectiveness of internal controls over financial reporting as of the fiscal year-end (February 29, 2024). This directly corresponds to the definition of an Audit Report / Information (AR), which covers internal or regulatory stress tests and applied accounting principles, although 'AR' is the closest fit among the provided codes for a formal internal control assessment report, distinct from a full 10-K or a simple earnings release.
2024-05-29 Japanese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.